Formulations for treatment of ocular diseases or conditions
Номер патента: EP2187743A2
Опубликовано: 26-05-2010
Автор(ы): David A. Weber, Philippe Jm Dor, Sidiq Farooq, Sreenivasu Mudumba, Sudeep Kaur Takhar, Thierry Nivaggioli
Принадлежит: MacuSight Inc
Опубликовано: 26-05-2010
Автор(ы): David A. Weber, Philippe Jm Dor, Sidiq Farooq, Sreenivasu Mudumba, Sudeep Kaur Takhar, Thierry Nivaggioli
Принадлежит: MacuSight Inc
Реферат: Described herein are liquid formulations which deliver a variety of therapeutic agents, including but not limited to rapamycin, to a subject for an extended period of time; liquid formulations which form a non-dispersed mass when placed in an aqueous medium; nondispersed mass-forming liquid formulations which form a gel or gel-like substance in an aqueous medium; liquid formulations, comprising a therapeutic agent and polymers; and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations. The liquid formulation may be placed in an aqueous medium of a subject, including via intraocular or periocular administration, or placement proximate to a site of a disease or condition to be treated in a subject. A method may be used to administer rapamycin to treat or prevent angiogenesis, choroidal neovascularization, or age-related macular degeneration, or wet age- related macular degeneration.
Treatment of Ocular Diseases
Номер патента: US20140010806A1. Автор: Christopher L. Reading,James M. Frincke,Clarence N. Ahlem. Владелец: Individual. Дата публикации: 2014-01-09.